Nuvation Bio Inc. (NUVB)

Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	14.36	7.87	-	-	-	-
Cost of Revenue	10.4	7.08	-	-	-	-
Gross Profit	3.95	0.8	-	-	-	-
Selling, General & Admin	119.6	69.23	28.53	31.92	24.28	10.95
Research & Development	-316.08	99.12	71.29	87.82	65.25	32.6
Operating Expenses	-196.48	168.35	99.82	119.73	89.53	43.55
Operating Income	200.43	-167.56	-99.82	-119.73	-89.53	-43.55
Interest Expense	-0.68	-0.34	-	-	-	-
Interest & Investment Income	22.89	27.06	24.61	7.45	2.96	1.95
Other Non Operating Income (Expenses)	-0.43	-2.02	-0.45	9.32	3.59	-0.27
EBT Excluding Unusual Items	222.21	-142.86	-75.66	-102.97	-82.98	-41.88
Gain (Loss) on Sale of Investments	-0	-0.01	-0.14	-1.23	-0.08	0.22
Pretax Income	-202.9	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income	-202.9	-567.94	-75.8	-104.2	-86.85	-41.66
Net Income to Common	-202.9	-567.94	-75.8	-104.2	-86.85	-41.66
Shares Outstanding (Basic)	323	269	219	217	198	98
Shares Outstanding (Diluted)	323	269	219	217	198	98
Shares Change (YoY)	43.13%	22.79%	1.00%	9.52%	102.90%	-52.81%
EPS (Basic)	-0.63	-2.11	-0.35	-0.48	-0.44	-0.43
EPS (Diluted)	-0.63	-2.11	-0.35	-0.48	-0.44	-0.43
Free Cash Flow	-168.58	-130.58	-68.07	-96.48	-68.47	-36.67
Free Cash Flow Per Share	-0.52	-0.49	-0.31	-0.45	-0.35	-0.38
Gross Margin	27.54%	10.10%	-	-	-	-
Operating Margin	1396.27%	-2128.25%	-	-	-	-
Profit Margin	-1413.43%	-7213.76%	-	-	-	-
Free Cash Flow Margin	-1174.36%	-1658.52%	-	-	-	-
EBITDA	201.48	-166.87	-99.6	-119.54	-89.35	-43.45
D&A For EBITDA	1.05	0.68	0.22	0.2	0.18	0.1
EBIT	200.43	-167.56	-99.82	-119.73	-89.53	-43.55

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q